Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Triple Negative Breast Neoplasms 1 Peritoneal Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Neoplasm, Residual 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Melanoma 1 HER2 Negative Breast Cancer 1 Carcinoma, Ovarian Epithelial 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × HER2 Negative Breast Cancer × Chemotherapy, Adjuvant × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡